Goodwill and Intangibles

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill by reportable operating segment for the nine months ended September 30, 2015 are summarized as follows:



	North America			Europe			South America		Asia Pacific			Total
Balance at January 1, 2015	$	117,609		$	12,366		$	—	$	5,194		$	135,169
Acquisition	—			—			—		18,977			18,977
Foreign exchange translation	(767		)	(1,001		)	—		(423		)	(2,191		)
Balance at September 30, 2015	$	116,842		$	11,365		$	—	$	23,748		$	151,955

Goodwill is not amortized, but is tested for impairment by reporting unit either annually or when events or circumstances indicate that impairment may exist. There were no indicators of potential impairment as of September 30, 2015.

The following table presents intangible assets and accumulated amortization balances of the Company as of December 31, 2014 and September 30, 2015, respectively:



	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer relationships	$	133,471	$	(59,773	)	$	73,698
Developed technology	9,252		(6,842		)	2,410
Other	6,701		(500		)	6,201
Balance at December 31, 2014	$	149,424	$	(67,115	)	$	82,309

Customer relationships	$	132,691	$	(66,050	)	$	66,641
Developed technology	8,948		(7,475		)	1,473
Other	10,487		(4,487		)	6,000
Balance at September 30, 2015	$	152,126	$	(78,012	)	$	74,114

Amortization expense totaled $3,892 and $3,599 for the three months ended September 30, 2014 and 2015, respectively, and $12,325 and $10,819 for the nine months ended September 30, 2014 and 2015, respectively. Amortization expense is estimated to be approximately $14,400 for the year ending December 31, 2015.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details